Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...
St. Jude Medical’s (STJ) Amplatzer PFO Occluder has finally returned to the US market after a decade in the wilderness. The device, used to plug a hole in the heart and thereby prevent recurrent ...
Results offer compelling evidence for closure with the AMPLATZER PFO Occluder over conventional medical management alone ST. PAUL, Minn. -- St. Jude Medical, Inc., a medical device company, today ...
A group of physicians assembled Tuesday on behalf of the FDA to rule that St. Jude Medical’s new heart device appears safe and effective in stroke prevention, according to the Minneapolis Star Tribune ...
- Patent Foramen Ovale (PFO) Closure Devices Market size is expected to rise by 2026 owing to increasing prevalence, escalating preferences for minimally-invasive, safety, technically feasible ...
MIAMI, FL – A clinical trial that compared catheter-based PFO closure using an investigational device found that there was no significant reduction in ischemic and bleeding events compared to standard ...
Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...
Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback